LabConnect, A Lab Like No Other
LabConnect is redefining central laboratory services as a technology driven partner for pharmaceutical and biotechnology companies. Our decentralized network model provides sponsors with access to the industry's most comprehensive global testing menu, supported by advanced sample tracking, data management, and expert consulting services.
With an asset light approach spanning functional service provider solutions, specialty testing, and ancillary support, we deliver scalability and efficiency beyond the limits of traditional laboratory ownership. By building the lab network of the future, LabConnect accelerates the development of life-changing therapies with greater precision, flexibility, and speed.
Tomorrow's World Today is an Emmy-nominated and Telly Award winning series exploring the latest advancements in science, sustainability, innovation, and technology.
Airing on Science Channel and Discovery Channel, the show uncovers compelling stories behind transformative ideas and solutions that are redefining how we live, work, and interact with our world.
The LabConnect episode features interviews with Chief Executive Officer Wes Wheeler, Chief Commercial and Strategy Officer Julia Tarasenko, and Chief Technology Officer Charles Castano. Together, they share what makes LabConnect "a lab like no other", from its global footprint and custom kit-building capabilities to its technology-driven approach that delivers new levels of flexibility, scalability, and efficiency for clinical trials worldwide.
A Conversation with the CEO
LabConnect CEO Wes Wheeler sat down with the team at Tomorrow's World Today to discuss how our lab-agnostic model, purpose-built software, and disciplined process design are transforming global clinical research. In the podcast, Wes breaks down how LabConnect enables speed, scale, and flexibility across key regions with a tech-enabled ecosystem, converting specialty testing into submission-ready data.
Looking ahead, Wes explores how AI, machine learning, and digital twins are reshaping clinical development—from modeling preclinical safety to identifying recruitable patient populations and flagging anomalies before they impact results. With cell and gene therapies, antibody-drug conjugates, and radiopharma driving the next wave of precision medicine, he shares how LabConnect's innovation mindset keeps trials moving forward.
Partner With Us
Request a quote from our dedicated team by filling out the form today.
